Loading...
Cardiotoxicity Assessment After Different Adjuvant Hypofractionated Radiotherapy Concurrently Associated with Trastuzumab in Early Breast Cancer
Aim: To evaluate cardiotoxicity in patients with human epidermal growth factor receptor 2+ (HER2+) breast cancer (29 left-sided, 23 right-sided) treated with adjuvant whole-breast hypofractionated radiotherapy (HRT) concurrently administered with the humanized monoclonal antibody to HER2, trastuzuma...
Saved in:
| Published in: | In Vivo |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
International Institute of Anticancer Research
2018
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6117770/ https://ncbi.nlm.nih.gov/pubmed/29936473 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/invivo.112322 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|